Cargando…
Well-differentiated gastroenteropancreatic G3 NET: findings from a large single centre cohort
Neuroendocrine neoplasms are known to have heterogeneous biological behavior. G3 neuroendocrine tumours (NET G3) are characterized by well-differentiated morphology and Ki67 > 20%. The prognosis of this disease is understood to be intermediate between NET G2 and neuroendocrine carcinoma (NEC). Cl...
Autores principales: | Lithgow, K., Venkataraman, H., Hughes, S., Shah, H., Kemp-Blake, J., Vickrage, S., Smith, S., Humphries, S., Elshafie, M., Taniere, P., Diaz-Cano, S., Dasari, B. V. M., Almond, M., Ford, S., Ayuk, J., Shetty, S., Shah, T., Geh, I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429701/ https://www.ncbi.nlm.nih.gov/pubmed/34504148 http://dx.doi.org/10.1038/s41598-021-97247-x |
Ejemplares similares
-
NETest: serial liquid biopsies in gastroenteropancreatic NET surveillance
por: van Treijen, Mark J C, et al.
Publicado: (2022) -
Casting a Wider NET: Pancreatic Exocrine Insufficiency Induced by Somatostatin Analogues among Patients with Neuroendocrine Tumours?
por: Hall, Lewis A., et al.
Publicado: (2023) -
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)
por: Ramage, John K, et al.
Publicado: (2011) -
Novel therapeutics for patients with well-differentiated gastroenteropancreatic neuroendocrine tumors
por: Das, Satya, et al.
Publicado: (2021) -
GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS (GEP-NETs) - APPROACH TO DIAGNOSIS AND MANAGEMENT
por: Oladejo, A.O.
Publicado: (2009)